PDS0101: Clinical Trials

2 trials of PDS0101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Completed 1

Follow PDS0101: new trials by email Literature Review of PDS0101 trials Research Report on PDS0101

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Pembrolizumab, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma
Phase 1 / Phase 2Active not recruitingMayo Clinic202022-06-162026-10-07
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
PDS0101, M7824, NHS-IL12 - Cervical Cancer, HPV Cancers
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)512020-06-092026-06-30

Conditions studied

Oropharyngeal Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Carcinoma (1)  ·  Rectal Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Charalampos Floudas, M.D. (1)  ·  David M. Routman, M.D. (1)

Results publications

PMID 39976981